PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 193 filers reported holding PDL BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $30,000 | -31.8% | 13,018 | -18.7% | 0.00% | -50.0% |
Q4 2017 | $44,000 | -18.5% | 16,018 | 0.0% | 0.01% | -14.3% |
Q3 2017 | $54,000 | +68.8% | 16,018 | +23.0% | 0.01% | +75.0% |
Q2 2017 | $32,000 | +45.5% | 13,018 | +23.2% | 0.00% | +33.3% |
Q4 2016 | $22,000 | – | 10,563 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Argent Trust Co | 41,405 | $102,270 | 0.01% |
Diversified Trust Co | 11,029 | $26,469 | 0.00% |
HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
Ancora Advisors LLC | 4,948 | $0 | 0.00% |
Westside Investment Management, Inc. | 500 | $0 | 0.00% |